Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Roxadustat and the Interpretation of Non-Inferiority

Roxadustat and the Interpretation of Non-Inferiority

FromJournal of the American Society of Nephrology (JASN)


Roxadustat and the Interpretation of Non-Inferiority

FromJournal of the American Society of Nephrology (JASN)

ratings:
Length:
16 minutes
Released:
Apr 11, 2022
Format:
Podcast episode

Description

In this Podcast, JASN EIC, Josie Briggs, discusses a clinical trial from the April issue on roxadustat in dialysis patients with Magdalene Assimon. Dr. Assimon explains the interpretation of the finding that roxadustat is non-inferior to epoetin alpha.
Released:
Apr 11, 2022
Format:
Podcast episode

Titles in the series (50)

JASN, the flagship journal of the ASN, publishes original research reports and basic and clinical science papers relevant to the broad discipline of nephrology. The JASN Podcast features discussions with authors of recently published articles. Moderated by JASN EIC, Josie Briggs, and the editorial fellows, each episode gives a behind the scenes look into the conception of the latest journal articles. New episodes monthly.